Literature DB >> 21460874

CMV encephalitis in BMT recipients.

H Sarva, J Graber, R Remanan, M Rosenblum, A Omuro.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21460874     DOI： 10.1038/bmt.2011.80

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

Review 1.  Opportunistic infections of the central nervous system in the transplant patient.

Authors:  Bruce A Cohen; Valentina Stosor
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

2.  Standard treatment-refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin.

Authors:  Natalia Maximova; Annalisa Marcuzzi; Irene Del Rizzo; Davide Zanon; Alessandra Maestro; Egidio Barbi; Roberto Sala
Journal:  Clin Transl Immunology       Date:  2020-11-17

Review 3.  Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Authors:  P Fillatre; Y Crabol; P Morand; L Piroth; J Honnorat; J P Stahl; M Lecuit
Journal:  Med Mal Infect       Date:  2017-03-15       Impact factor: 2.152

4.  Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation.

Authors:  Ian Pang; Sanjay Singhabahu; Igor Novitzky-Basso; Tony Mazzulli; Shahid Husain; Jonas Mattsson
Journal:  IDCases       Date:  2022-08-19

5.  Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients.

Authors:  Anna Amelia Colombo; Giovanna Giorgiani; Vanina Rognoni; Paola Villani; Milena Furione; Mario Regazzi Bonora; Emilio Paolo Alessandrino; Marco Zecca; Fausto Baldanti
Journal:  BMC Infect Dis       Date:  2012-10-03       Impact factor: 3.090

Review 6.  Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System.

Authors:  Janaki Manoja Vinnakota; Robert Zeiser
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.